These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. Cuocolo A; Pace L; Ricciardelli B; Chiariello M; Trimarco B; Salvatore M J Nucl Med; 1992 Apr; 33(4):505-11. PubMed ID: 1552332 [TBL] [Abstract][Full Text] [Related]
23. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Ichiyanagi K; Hisada K J Nucl Med; 1995 Nov; 36(11):1961-7. PubMed ID: 7472582 [TBL] [Abstract][Full Text] [Related]
24. Single-photon perfusion imaging for the assessment of myocardial viability. Hendel RC J Nucl Med; 1994 Apr; 35(4 Suppl):23S-31S. PubMed ID: 8151409 [TBL] [Abstract][Full Text] [Related]
25. Thallium-201 reverse redistribution at reinjection imaging correlated with coronary lesion, wall motion abnormality and tissue viability. Marzullo P; Gimelli A; Cuocolo A; Pace L; Marcassa C; Sambuceti G; Galli M; Giorgetti A; Stefanini S; Parodi O; L'Abbate A J Nucl Med; 1996 May; 37(5):735-41. PubMed ID: 8965136 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of coronary angiography in patients with chronic ischemic left ventricular dysfunction and evidence of viable myocardium on thallium reinjection imaging. Petretta M; Cuocolo A; Bonaduce D; Nicolai E; Vicario ML; Salvatore M J Nucl Cardiol; 1997; 4(5):387-95. PubMed ID: 9362015 [TBL] [Abstract][Full Text] [Related]
27. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability. Berman DS; Kiat H; Van Train KF; Friedman J; Garcia EV; Maddahi J Am J Cardiol; 1990 Oct; 66(13):72E-79E. PubMed ID: 2145750 [TBL] [Abstract][Full Text] [Related]
28. Assessment of myocardial perfusion and metabolism for assessment of myocardial viability. Beller GA Q J Nucl Med; 1996 Mar; 40(1):55-67. PubMed ID: 8681014 [TBL] [Abstract][Full Text] [Related]
29. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET. Tamaki N; Ohtani H; Yonekura Y; Shindo M; Nohara R; Kambara H; Kawai C; Hirata K; Ban T; Konishi J J Cardiol; 1992; 22(2-3):283-93. PubMed ID: 1339787 [TBL] [Abstract][Full Text] [Related]
30. Relationship between reverse redistribution on planar thallium scintigraphy and regional myocardial viability: a correlative PET study. Soufer R; Dey HM; Lawson AJ; Wackers FJ; Zaret BL J Nucl Med; 1995 Feb; 36(2):180-7. PubMed ID: 7830110 [TBL] [Abstract][Full Text] [Related]
31. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease. Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Tonami N; Hisada K Am J Cardiol; 1996 Feb; 77(5):350-4. PubMed ID: 8602561 [TBL] [Abstract][Full Text] [Related]
32. Rest or redistribution thallium myocardial imaging for resting myocardial perfusion: a detailed comparison with regional wall motion. Woldman S; Martin W; Hutton I Nucl Med Commun; 1996 Oct; 17(10):843-50. PubMed ID: 8951904 [TBL] [Abstract][Full Text] [Related]
33. Improved detection of viable myocardium with thallium-201 reinjection in chronic coronary artery disease: comparison with technetium-99m-MIBI imaging. Maurea S; Cuocolo A; Nicolai E; Salvatore M J Nucl Med; 1994 Apr; 35(4):621-4. PubMed ID: 8151385 [TBL] [Abstract][Full Text] [Related]
34. The noninvasive assessment of myocardial viability. Ragosta M; Beller GA Clin Cardiol; 1993 Jul; 16(7):531-8. PubMed ID: 8348761 [TBL] [Abstract][Full Text] [Related]
35. Theoretical model for myocardial functional characterization: application to a group of patients evaluated before and after surgical revascularization. Bontemps L; Nazzi M; Gabain M; Jegaden O; Felecan R; Itti R J Nucl Cardiol; 1998; 5(2):134-43. PubMed ID: 9588665 [TBL] [Abstract][Full Text] [Related]
36. Assessing myocardial viability to help select patients for revascularization to improve left ventricular dysfunction due to coronary artery disease. Patterson RE; Pilcher WC Semin Thorac Cardiovasc Surg; 1995 Oct; 7(4):214-26. PubMed ID: 8590746 [TBL] [Abstract][Full Text] [Related]
37. Comparison of exercise radionuclide angiography with thallium SPECT imaging for detection of significant narrowing of the left circumflex coronary artery. Dilsizian V; Perrone-Filardi P; Cannon RO; Freedman NM; Bacharach SL; Bonow RO Am J Cardiol; 1991 Aug; 68(4):320-8. PubMed ID: 1858674 [TBL] [Abstract][Full Text] [Related]
38. Immediate 201Tl reinjection: an alternative approach in myocardial perfusion scintigraphy? A comparison with contrast angiographic findings. van Eck-Smit BL; van der Wall EE; Zwinderman AH; Pauwels EK Nucl Med Commun; 1995 Oct; 16(10):811-20. PubMed ID: 8570110 [TBL] [Abstract][Full Text] [Related]
39. [Ischemic myocardial injury evaluated using positron emission tomography in children with coronary artery disease: comparison with thallium-201 SPECT]. Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Yonekura Y; Yamashita K; Konishi J; Ban T; Mikawa H J Cardiol; 1992; 22(1):21-6. PubMed ID: 1307567 [TBL] [Abstract][Full Text] [Related]
40. Combined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunction. Petretta M; Cuocolo A; Nicolai E; Acampa W; Salvatore M; Bonaduce D J Nucl Cardiol; 1998; 5(4):378-86. PubMed ID: 9715982 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]